Dermapharm Holding SE (FRA:DMP)
Germany
· Delayed Price · Currency is EUR 39.60
+0.25 (0.64%)
Last updated: May 13, 2025
Dermapharm Holding SE Revenue
In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B EUR with 3.89% growth. Dermapharm Holding SE had revenue of 295.67M in the quarter ending December 31, 2024, with 7.85% growth.
Revenue
1.20B
Revenue Growth
+3.89%
P/S Ratio
1.78
Revenue / Employee
331.15K
Employees
3,610
Market Cap
2.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.20B | 44.72M | 3.89% |
| Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
| Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
| Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
| Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 76.54B |
| Deutsche Telekom AG | 118.43B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Merck KGaA | 21.16B |
Dermapharm Holding SE News
- 4 weeks ago - EQS-PVR: Dermapharm Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 5 weeks ago - EQS-DD: Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy - Wallstreet:Online
- 6 weeks ago - Dermapharm's 2024: Revenue Soars, Surpassing EBITDA Expectations - Wallstreet:Online
- 6 weeks ago - EQS-News: Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance - Wallstreet:Online
- 2 months ago - EQS-DD: Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy - Wallstreet:Online
- 2 months ago - Dermapharm Surpasses EBITDA Forecast with Revenue Boost - Wallstreet:Online
- 2 months ago - EQS-News: Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA - Wallstreet:Online